Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group (Q59616816)
Jump to navigation
Jump to search
scientific article published on 11 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group |
scientific article published on 11 December 2006 |
Statements
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group (English)
Brigitte Mlineritsch
Gero Luschin-Ebengreuth
Stephan Grampp
Helmut Kaessmann
Marianne Schmid
Christian Menzel
Jutta Claudia Piswanger-Soelkner
Arik Galid
Martina Mittlboeck
Hubert Hausmaninger
Raimund Jakesz
Austrian Breast and Colorectal Cancer Study Group
11 December 2006